The Japanese pharmaceutical company “Kyokuto” was ordered by the Toyama Prefectural Government of Japan to stop production and sales for 23 days and 22 days, respectively, due to falsification of data shipments after producing the gastrointestinal drug “Zenro Pill,” which had insufficient ingredients. The decision will be officially implemented on April 30. It has been known that Kyokuto falsified drug test data for 30 years. Faced with questions from the public and relevant parties, Kyokudong acknowledged that it had been manipulating drug test results 30 years ago, and apologized for its lack of awareness of compliance with regulations. The company promised to deal seriously with this incident, work to restore consumer trust, and thoroughly investigate to prevent similar incidents from happening again.
胃肠药“正露丸”数据造假30年，日本药厂极东被勒令暂时停产停售
Data on the gastrointestinal drug “Zhenglu Pill” has been falsified for 30 years, and the Japanese pharmaceutical company Kyokuto was ordered to temporarily stop production and sales
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.